Cargando…
Broad-spectrum therapeutics: A new antimicrobial class
There are currently no emergency treatments for pandemics, yet drug repositioning has emerged as the foremost treatment development strategy for COVID-19, with an aim to identify successful antiviral therapeutics from safe, non-antiviral candidates. These therapeutics include antibiotics such as azi...
Autores principales: | Firth, Anton, Prathapan, Praveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035643/ https://www.ncbi.nlm.nih.gov/pubmed/34870144 http://dx.doi.org/10.1016/j.crphar.2020.100011 |
Ejemplares similares
-
Azithromycin: The First Broad-spectrum Therapeutic
por: Firth, Anton, et al.
Publicado: (2020) -
WITHDRAWN: Azithromycin: The First Broad-spectrum
Therapeutic
por: Kruger, Donna, et al.
Publicado: (2020) -
Quinolone-3-amidoalkanol:
A New Class of Potent and
Broad-Spectrum Antimicrobial Agent
por: Dube, Phelelisiwe S., et al.
Publicado: (2023) -
A determination of pan-pathogen antimicrobials?
por: Prathapan, Praveen
Publicado: (2022) -
Nanoparticles as potential new generation broad spectrum antimicrobial agents
por: Yah, Clarence S., et al.
Publicado: (2015)